Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
$21.10
$0.06(0.19%)
At close: 4:00 PM EST
$21.10
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.56 - $39.97
Previous CloseN/A
Volume92.25K
Average Volume (3M)512.71K
Market Cap
$1.06B
Enterprise Value$1.56B
Total Cash (Recent Filing)$463.45M
Total Debt (Recent Filing)$1.09B
Price to Earnings (P/E)97.8
Beta1.09
Next Earnings
Mar 02, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding50,155,613
10 Day Avg. Volume740,491
30 Day Avg. Volume512,710
Financial Highlights & Ratios
PEG Ratio-1.16
Price to Book (P/B)2.11
Price to Sales (P/S)0.74
P/FCF Ratio34.04
Enterprise Value/Market Cap1.47
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit5.30
Enterprise Value/Ebitda14.40
Forecast
1Y Price Target
$33.20Price Target Upside57.35% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow And DeleveragingStrong free cash flow generation positions the company to reach post-acquisition leverage targets ahead of plan, improving flexibility for reinvestment or capital returns.
Strategic Partnerships And Market ExpansionNew partnerships, including an agreement to expand operations in southern Nevada and a provider arrangement in Southern California, broaden market access and add meaningful value-based members to growth pipelines.
Valuation OpportunityDepressed share price relative to consensus FY26 EBITDA creates a valuation gap that could drive upside if investors re-rate the stock as growth and operational catalysts materialize.
Bears Say
Contract Conversion Delays And Guidance UncertaintyDelays in converting contracts to full-risk arrangements have reduced investor confidence and prompted guidance adjustments, increasing uncertainty around FY26 operating performance.
Medicare Advantage Policy RiskA government proposal for Medicare Advantage rates disappointed investors and may pressure revenue expectations for companies with substantial exposure to Medicare plans.
Regulatory Headwinds For Remote Diagnosis MethodsProposed rules that would disallow diagnoses from audio-only encounters and certain chart reviews create operational risk for providers that rely on those remote diagnosis sources.
Astrana Health News
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $18.56 and its highest was $39.97 in the past 12 months.
What is Astrana Health’s market cap?
Astrana Health’s market cap is $1.06B.
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is Mar 02, 2026 which is in 20 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Nov 06, 2025. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.466 by -$0.456.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is 0.11.
How many shares outstanding does Astrana Health have?
Astrana Health has 50,155,613 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of $0.01 in its last earnings report, missing expectations of $0.466. Following the earnings report the stock price went down -23.441%.
Which hedge fund is a major shareholder of Astrana Health?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$33.20 (57.35% Upside)
$33.20 (57.35% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 68.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 7.3%
Last 30 Days ▼ 7.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.69%
12-Months-Change
Fundamentals
Return on Equity
1.29%
Trailing 12-Months
Asset Growth
74.05%
Trailing 12-Months
Company Description
Astrana Health
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Company Deck
ASTH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Astrana Health's earnings call highlighted significant revenue and EBITDA growth, successful integration of Prospect Health, and technological advancements. However, delays in full risk contract transitions and potential Medicaid headwinds presented challenges. The positive aspects, including strong financial performance and strategic partnerships, were more prominent.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$33.20
▲(57.35% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
47.32% Insiders
17.79% Mutual Funds
1.49% Other Institutional Investors
12.41% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---